U.S. Media Stock News

Wondering if Tenet Healthcare at around US$192.99 is still priced for opportunity or if most of the value is already on the table? This article focuses squarely on what the current share price might be implying. The stock has seen mixed recent returns, with a 1.4% move over the last 7 days, a 15.2% decline over 30 days, and a 3.2% decline year to date, set against a 54.5% return over the past year and a 195.9% return over 3 years. Recent headlines around Tenet Healthcare have centered on its...

Why Westlake stock is on investors’ radar Westlake (WLK) has drawn renewed attention after recent trading, with the share price at $120.15 and returns over the month, past 3 months, and year pointing to meaningful moves investors may want to contextualize. See our latest analysis for Westlake. The recent 1-day share price return of 1.50% and 30-day share price return of 7.24%, building on a 62.04% year to date share price return, point to strengthening momentum. The 36.95% 1-year total...

Recently, Graham Corp appeared on a Minervini Trend Template and High Growth Momentum screen after a period of strong earnings and revenue growth, consistently surpassing analyst EPS expectations with improving profit margins. This combination of accelerating fundamental performance and technically strong price action has put Graham on the radar of growth-focused investors assessing its operational progress. We’ll now explore how this stronger-than-expected earnings momentum could influence...

In the past few days, CNH Industrial reported its fourth-quarter and full-year 2025 results, highlighting softer equipment demand alongside operational progress and lower dealer inventories. At the same time, differing analyst views following the update have sharpened the debate over how effectively CNH Industrial is managing through a weaker machinery cycle. We’ll now explore how CNH Industrial’s weaker equipment demand yet improved operational execution may influence its existing...

In early April 2026, several law firms announced securities class action lawsuits against Upstart Holdings and certain executives, alleging false and misleading statements about its Model 22 AI lending platform and 2025 revenue guidance following weaker-than-guided results in late 2025. The complaints center on whether Upstart’s flagship AI model systematically misjudged macroeconomic risk and loan approvals, raising questions about the transparency and robustness of its core technology...

Amkor Technology recently reported past quarterly results that surpassed analyst expectations for revenue and earnings, helping to underpin strong operating momentum in its outsourced semiconductor packaging and testing business. At the same time, an insider option exercise by Robert R. Morse and concerns about a richer valuation have drawn attention to how much optimism is already reflected in the company’s investment case. We’ll now examine how Amkor’s earnings outperformance shapes its...

USA Rare Earth: stock snapshot and recent moves Without a specific news catalyst in play, USA Rare Earth (USAR) has still seen active trading, with the share price at US$16.79, a 1 day return of 3.96% and a past month decline of 13.72%. See our latest analysis for USA Rare Earth. That recent 9.88% 7 day share price return partly offsets the 13.72% 30 day share price decline, and sits alongside an 18.66% year to date share price return and 42.89% 1 year total shareholder return. This hints at...

Klarna Group (NYSE:KLAR) has partnered with German gaming retailer Mindfactory to roll out its payment solutions across Mindfactory's online channels. The agreement extends Klarna's offering into Germany's gaming retail segment, adding a new consumer category to its merchant base. This move follows earlier expansions into Southern Europe, but targets a different vertical and geography that has not featured in recent coverage. Klarna's partnership with Mindfactory comes at a time when the...

Evergy (EVRG) has drawn fresh attention after recent share moves, with the stock showing mixed short term performance but a stronger performance over the past 3 months and 1 year in terms of total return for investors. See our latest analysis for Evergy. The recent 1 day and 7 day share price declines contrast with a stronger 90 day share price return of 9.6% and a 1 year total shareholder return of 26.1%. This points to momentum building over the longer stretch even as short term sentiment...

Guidewire Software (GWRE) is back in focus after a sharp sector driven selloff, as investors weigh recent price declines against strong earnings, fresh client wins, and rising concerns about AI driven competition. See our latest analysis for Guidewire Software. Despite a 5.3% 1 day share price gain to US$124.18, the 30 day share price return of 22.66% and year to date share price return of 33.82% point to fading momentum after a strong 3 year total shareholder return of 58.47%. If you are...

Recently, analyst coverage highlighted Mercury General within the broader property and casualty insurance group, emphasizing its prudent underwriting, exposure growth, digital initiatives, and strong liquidity profile alongside a top industry ranking and upbeat earnings estimates. Separately, Mercury Insurance issued safety guidance on driving in wet spring conditions, underscoring the company’s focus on risk prevention and loss mitigation as part of its broader operational approach. With...

In early April 2026, Modine Manufacturing drew attention after fresh analyst research highlighted the company’s expanding data center and Climate Solutions businesses, supported by its global expansion in thermal management markets. A key development was the disclosure of President of Data Centers Laszlo Arthur Jr.’s initial equity stake, underscoring management’s direct alignment with Modine’s long-term growth initiatives in advanced cooling solutions. Next, we’ll examine how this upbeat...

American Express, through Amex Ventures, has invested in Palm, a business identity infrastructure platform. The deal focuses on building out API driven business identity networks for corporate and financial services use. This move extends American Express's activity beyond traditional card operations into secure digital identity for business payments. For investors watching NYSE:AXP, this investment sits alongside a share price of $323.82 and multi year returns that have been strong,...

In recent weeks, EchoStar finalized an agreement to transfer certain spectrum licenses to SpaceX in return for an equity stake, giving its investors indirect exposure to a potential SpaceX IPO while regulatory decisions around satellite spectrum-sharing and Starlink’s buildout have been moving forward. This development has sharpened attention on how a SpaceX shareholding and spectrum monetization might offset EchoStar’s high debt levels and pressure on its legacy Pay-TV, wireless, and...

In April 2026, Anthropic and Moody’s Corporation announced that Moody’s Agentic Solutions will be embedded directly into Anthropic’s Claude platforms via a Model Context Protocol application, allowing credit analysis and compliance workflows to run natively inside Claude with explainable, auditable outputs for regulated institutions. This integration effectively turns Claude into a front-end for Moody’s risk intelligence across hundreds of millions of entities and billions of ownership...

If you are wondering whether T-Mobile US is priced attractively or stretched at current levels, this article walks through what the numbers say about its valuation. The stock last closed at US$192.43, with returns of 3.1% decline over 7 days, 11.5% decline over 30 days, 3.6% decline year to date, 25.5% decline over 1 year, 33.0% over 3 years, and 51.6% over 5 years, which gives important context before looking at valuation. Recent news coverage around T-Mobile US has focused on ongoing...

Over the last 7 days, the United States market has risen by 4.2%, contributing to a substantial 29% climb over the past year, with earnings forecasted to grow by 16% annually. In this environment, identifying stocks that are both undervalued and have insider buying can present intriguing opportunities for investors seeking potential growth within small-cap sectors.

What Black Hills Does and Where the Money Comes From Black Hills (BKH) runs regulated electric and natural gas utilities across several U.S. states, with operations organized into Electric Utilities and Gas Utilities, plus a smaller corporate and other segment. Gas Utilities generated about US$1,382.8m of revenue. Electric Utilities, which includes power generation and mining, generated US$942.8m, while corporate and other activities reduced the total by US$15.6m. Across the group, revenue...

Fiserv's Board is opposing a shareholder proposal to permanently separate the Chairman and CEO roles. The proposal will be voted on at the company’s annual meeting scheduled for May 2026. The Board is urging shareholders to vote against the governance change. For investors watching NasdaqGS:FISV, this governance question comes on top of a mixed recent share price record. The stock closed at $58.79, with a 6.3% gain over the past week and a 3.6% return over the past 30 days, while year to...

Revolve Group (RVLV) is back in focus after fresh commentary flagged its shares as trading above intrinsic value, alongside insider stock sales, softer active customer trends, and stalled earnings per share growth. See our latest analysis for Revolve Group. After a sharp share price drop around the recent overvaluation and insider selling headlines, Revolve Group’s 1 day share price return of 2.04% and 7 day return of 6.87% contrast with a 90 day share price return of negative 20.06% and a 5...

The United States market has shown robust growth, rising 4.2% over the last week and 29% over the past year, with earnings projected to increase by 16% annually. In such a thriving environment, identifying stocks that may be undervalued requires careful consideration of their potential for growth relative to current market conditions.

In early April 2026, Vertex Pharmaceuticals reported that the U.S. FDA approved expanded use of its cystic fibrosis therapies ALYFTREK and TRIKAFTA, making CFTR modulator treatment available to roughly 95% of people with cystic fibrosis in the U.S., including about 800 individuals newly eligible for a therapy that targets the disease’s underlying cause. This broad label expansion deepens Vertex’s role in cystic fibrosis care and underscores the importance of its existing franchise even as...

DLocal Ltd. recently reported past-quarter earnings per share of US$0.18 on revenue of US$337.89 million, surpassing analyst expectations on both metrics and confirming strong operating performance in its 29-country payment platform. Beyond the headline beats, the results underscored how DLocal’s broad coverage of over 600 local payment methods is helping global merchants scale in emerging markets. Next, we’ll examine how this earnings and revenue surprise, alongside analysts’ projected...

Why Anbio Biotechnology Is On Investors’ Radar Anbio Biotechnology (NNNN) has seen sharp share price moves recently, with a 30 day return of about 39% and a past 3 months return of about 31% decline. This volatility has put its diagnostics-focused business in the spotlight. See our latest analysis for Anbio Biotechnology. The recent 39.2% 30 day share price return contrasts with a 30.6% decline over 90 days, while the 1 year total shareholder return of about 3.5x points to strong longer term...